PHARMACOLOGY 45.

NMB classification and MOA

46. DMR vs NDMR
1. Intravenous anesthetic agents 47. Succinylcholine
classification 48. Mechanism of succinylcholine
2. Propofol induced fasciculations
3. Ketamine 49. Atracurium
4. Benzodiazepines 50. Cis atracurium
5. Midazolam 51. Hoffman degradation
6. Remimazolam 52. Vecuronium
7. Diazepam 53. Rocuronium
8. Midazolam vs diazepam 54. mivacurium
9. Flumazenil 55. Suggamadex
10. Etomidate 56. ED95%
11. Thiopentone 57. True vs pseudocholinesterase
12. Thiopentone vs propofol 58. Train of four monitoring
13. Alfa 2 agonists 59. Residual muscle relaxation
14. Dexmedetomidine 60. Neuromuscular monitoring
15. Clonidine 61. Double burst monitoring
16. Dopamine 62. Neostigmine
17. Dobutamine 63. Pyridostigmine
18. Dopamine vs dobutamine 64. Dibucaine number
19. Milrinone 65. Local anesthetics MOA
20. Noradrenaline 66. Lignocaine
21. Atropine 67. Bupivacaine
22. Newer inotropes 68. Ropivacaine
23. Vasopressors 69. LAST
24. Ephedrine 70. Adjuvant for regional anesthesia
25. Opioids classification and MOA 71. Inhalation agents action on CNS
26. Carbon dioxide curve and opioids 72. MOA of inhalation agents
27. Morphine 73. Chloroform
28. Fentanyl 74. Isoflurane
29. Fentanyl patches 75. Sevoflurane
30. Remifentanil 76. Desflurane
31. sufentanyl 77. Enflurane
32. opioids drug delivery 78. Halothane
33. tramadol 79. Halothane hepatitis
34. butorphanol 80. Fluorocarbons
35. pentazocine 81. Low flow anesthesia
36. opioid partial agonist-antagonist 82. Blood gas coefficient
37. opioid free analgesia 83. Factors affecting uptake of inhalation
38. multimodal analgesia agents
39. target controlled infusion 84. Distribution and elimination of
40. extradural and intradural opioids inhalation agents
41. paracetamol 85. MAC
42. ziconotide 86. Xenon
43. preemptive analgesia 87. Ether
44. neuromuscular junction transmission 88. Methoxyflurane
89. Nitrous oxide 134. Spironolactone
90. Beta agonist 135. Renin angiotensin aldosterone
91. Betablockers classification and MOA 136. Aminophylline
92. Esmolol 137. Theophylline
93. Metoprolol 138. Vitamin K
94. Calcium channel blockers 139. Anti-epileptics classification
95. Anti-arrhythmic drugs 140. Phenytoin
96. Amiodarone 141. Carbamazepine
97. Digoxin 142. Drugs decreasing ICP
98. Levosimendan 143. Mannitol
99. Milrinone 144. Oxytocin
100. Insulin 145. Methergine
101. Antidiabetic meds 146. Carboprost
102. Glycemic control scales 147. Antibiotics
103. Azeotropic mixture 148. Nephrotoxic drugs
104. Optical purity of drugs 149. Anti-hypertensive drugs
105. Drug-drug interactions 150. Remdesvir
106. UFH 151. Covid medication (mild,
107. LMWH moderate,severe)
108. UFH vs LMWH 152. ANS pharmacology
109. Anticoagulants 153. Zero order and 1st order
110. Aspirin pharmacokinetics
111. Warfarin 154. 3 compartment model
112. Anticoagulants stopping before 155. Enzyme induction and anesthesia
surgery 156. Preconditioning by volatile agents
113. Clopidogrel 157. ICU Sedation
114. Tranexamic acid 158. Herbal toxicity
115. E caproic acid
116. Thyroid medications
117. Antidepressants
118. Vasodilators
119. Nitroglycerine
120. Sodium nitroprusside
121. Steroids in perioperative anesthesia
122. Steroids in ICU
123. Hydrocortisone
124. Dexamethasone
125. Steroid’s step ladder
126. Challenges of chronic steroid
therapy
127. Anti-aspiration prophylaxis
128. Ondansetron
129. Palonosetron
130. Metoclopramide
131. Ranitidine
132. Magnesium sulphate
133. Frusemide